Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin

被引：0
|
作者：
Muller, D. C. [1 ]
Bacon, J. V. W. [2 ]
Ritch, E. [2 ]
Dugas, S. G. [1 ]
Vandekerkhove, G. [2 ]
Annala, M. [3 ,4 ]
Black, P. C. [2 ]
Seifert, H. [1 ]
Bubendorf, L. [5 ]
Wyatt, A. W. [2 ]
Rentsch, C. A. [1 ]
机构：
[1] Univ Hosp Basel, Dept Urol, Basel, Switzerland
[2] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[3] Univ Tampere, Fac Med & Life Sci, Tampere, Finland
[4] Prostate Canc Res Ctr, BioMediTech Inst, Tampere, Finland
[5] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0445
引用
收藏
页码：S617 / S617
页数：1
相关论文
共 50 条
  • [21] CHARACTERIZATION OF THE URINARY MICROBIOME IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY
    Sweis, Randy
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Bloodworth, Jeffrey
    Werntz, Ryan
    Steinberg, Gary
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E621 - E621
  • [22] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
    Andrade, Danilo Leite
    Moretti, Tomas Bernardo Costa
    Neto, Wilmar Azal
    Benedetti, Julia
    Reis, Leonardo Oliveira
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
  • [23] INTRAVESICAL BACILLUS CALMETTE-GUERIN GLOBAL SHORTAGE: IMPACT ON THE MANAGEMENT OF NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Sengupta, Shomik
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 47 - 47
  • [24] Intravesical Bacillus Calmette-Guerin for non-muscle invasive urothelial carcinoma of the bladder - patterns of use, and impact on outcomes
    Azer, S.
    Ranasinghe, W.
    Gibson, L.
    Webb, C.
    Lioufas, P. A.
    Cetti, R.
    Frydenberg, M.
    Bolton, D.
    Appu, S.
    Sengupta, S.
    [J]. BJU INTERNATIONAL, 2015, 115 : 3 - 3
  • [25] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    [J]. DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
  • [26] Pyuria as a Predictive Marker of Bacillus Calmette-Guerin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
    Suh, Jungyo
    Yuk, Hyeong Dong
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [27] UTILIZATION PATTERNS OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR PATIENTS WITH HIGH-GRADE, NON-MUSCLE INVASIVE BLADDER CANCER
    Lenis, Andrew
    Litwin, Mark
    Saigal, Christopher
    Donin, Nicholas
    Lai, Julie
    Hanley, Jan
    Konety, Badrinath
    Chamie, Karim
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [28] Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage
    Chun, Brian
    He, Meiqi
    Jones, Cameron
    Vasan, Robin
    Gabriel, Nico
    Jacobs, Bruce L.
    Hernandez, Inmaculada
    Davies, Benjamin J.
    [J]. UROLOGY, 2023, 177 : 74 - 80
  • [29] CARCINOGENESIS AND BACILLUS CALMETTE-GUERIN (BCG) INTRAVESICAL TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER UNDER TRYPTOPHAN AND THYMINE SUPPLEMENTATION
    Ossick, Marina
    Kiehl, Isis
    Salustiano, Ana Clara
    Ferrari, Karen
    Degasperi, Giovanna
    Linarelli, Maria
    Reis, Leonardo
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E1133 - E1133
  • [30] The Correct Sequence of Intravesical Chemotherapy and Bacillus Calmette-Guerin for Non-Muscle-invasive Bladder Cancer
    Oosterlinck, Willem
    Decaestecker, Karel
    [J]. EUROPEAN UROLOGY, 2015, 67 (03) : 517 - 518
12345